- Home
- HIW vs RNA Comparison
HIW vs RNA Comparison
Compare HIW & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIW
- RNA
- Stock Information
- Founded
- HIW 1978
- RNA 2012
- Country
- HIW United States
- RNA United States
- Employees
- HIW N/A
- RNA N/A
- Industry
- HIW Real Estate Investment Trusts
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- HIW Real Estate
- RNA Health Care
- Exchange
- HIW Nasdaq
- RNA Nasdaq
- Market Cap
- HIW 3.1B
- RNA 3.4B
- IPO Year
- HIW 1994
- RNA 2020
- Fundamental
- Price
- HIW $30.13
- RNA $32.51
- Analyst Decision
- HIW Buy
- RNA Strong Buy
- Analyst Count
- HIW 6
- RNA 12
- Target Price
- HIW $31.83
- RNA $67.92
- AVG Volume (30 Days)
- HIW 921.4K
- RNA 1.4M
- Earning Date
- HIW 07-22-2025
- RNA 05-08-2025
- Dividend Yield
- HIW 6.73%
- RNA N/A
- EPS Growth
- HIW 32.01
- RNA N/A
- EPS
- HIW 1.60
- RNA N/A
- Revenue
- HIW $819,789,000.00
- RNA $8,927,000.00
- Revenue This Year
- HIW $0.43
- RNA N/A
- Revenue Next Year
- HIW $5.18
- RNA $148.12
- P/E Ratio
- HIW $18.51
- RNA N/A
- Revenue Growth
- HIW N/A
- RNA N/A
- 52 Week Low
- HIW $24.19
- RNA $21.51
- 52 Week High
- HIW $36.78
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- HIW 50.29
- RNA 55.75
- Support Level
- HIW $28.42
- RNA $30.15
- Resistance Level
- HIW $30.35
- RNA $32.09
- Average True Range (ATR)
- HIW 0.63
- RNA 1.69
- MACD
- HIW -0.09
- RNA 0.13
- Stochastic Oscillator
- HIW 36.81
- RNA 76.17
About HIW Highwoods Properties Inc.
Highwoods Properties Inc is a real estate investment trust engaged in the acquisition, ownership, management, and leasing of properties in urban areas throughout the Southern United States. In terms of total square footage, the vast majority of the company's real estate portfolio comprises office buildings in terms. Highwoods Properties derives nearly all of its income in the form of rental revenue from the tenants of its buildings. The majority of this revenue comes from its holdings in the urban markets of Atlanta, Raleigh, Nashville, and Tampa. These cities also account for the majority of the square footage under the company's ownership. Highwoods Properties customers include the U.S. Government, financial services firms, industrial supply retailers, and healthcare companies.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.